Press releaseGlobe Newswire
Aquestive Therapeutics
AQST · NASDAQ
$4.05+$0.22 (+5.74%)TodayMarket closed ·
Prev close $3.83
Latest news
- NewsVandana Singh
Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug
- Press releaseGlobe Newswire
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
- Press releasePRNewswire
Aquestive Therapeutics, Inc. (Nasdaq: AQST) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Following 37% Stock Drop
- Press releaseGlobe Newswire
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
- NewsVandana Singh
Aquestive Therapeutics Resubmits FDA Application for Pocket-Sized Allergy Treatment
- Press releaseGlobe Newswire
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
- Press releaseGlobe Newswire
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
- NewsVandana Singh
Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study
- NewsAvi Kapoor
Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On Monday
- Press releaseGlobe Newswire
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
- Press releaseGlobe Newswire
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
- NewsAvi Kapoor
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday
- News
Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
- News
Earnings Scheduled For May 13, 2026
- Press releaseGlobe Newswire
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
- Press releaseBusiness Wire
AQST FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
- Press releaseGlobe Newswire
AQUESTIVE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Large Losses They Have Until Monday May 4th to Seek Lead Plaintiff Role
- Press releaseGlobe Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 4, 2026 in Aquestive Therapeutics, Inc. Lawsuit - AQST
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST
- Press releasePRNewswire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
- Press releasePRNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Pattern Of Harm: SueWallSt
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors with Large Losses They Have Until Monday May 4th to Seek Lead Plaintiff Role
- Press releasePRNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Stock Dropped Over 37 Percent: Levi & Korsinsky
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST
- Press releasePRNewswire
AQST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aquestive Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm
- Press releaseGlobe Newswire
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
- Press releasePRNewswire
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- Press releaseGlobe Newswire
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
- Press releasePRNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: SueWallSt
- Press releasePRNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky
- Press releasePRNewswire
AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
- Press releasePRNewswire
AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Aquestive Therapeutics, Inc. Investors They Have Until May 4th to Seek Lead Plaintiff Role
- Press releaseBusiness Wire
Robbins LLP Urges AQST Stockholders to Contact the Firm for Information About the Class Action Against Aquestive Therapeutics, Inc.
- Press releasePRNewswire
AQST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aquestive Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm
- Press releaseGlobe Newswire
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
- Press releasePRNewswire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026
- Press releasePRNewswire
AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt
- Press releasePRNewswire
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky
- NewsVandana Singh
What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment?
- News
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet
- NewsAvi Kapoor
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
- NewsAvi Kapoor
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.